Regulatory feasibility assessment is one of the most important and first steps in conducting a clinical trial. It helps evaluate the compatibility of a clinical trial design, adhere to current regulatory requirements and compliances, and focus on safety and efficiency to conduct a proper clinical trial. This phenomenon works as a bridge between regulatory requirements and innovations, thereby improving the clinical trial landscape. Examining clinical trial regulations enables investigators to identify benchmarks and work on the approval process while minimizing potential risks.

The development of technology and globalization makes regulatory feasibility more important. It ensures that clinical trials meet necessary standards and ethical guidelines in innovating novel therapies and drugs. Aside from that, the regulatory feasibility assessment builds confidence between clinical trial participants and investigators, resulting in improved outcomes. With the global development of clinical trial processes, regulatory feasibility assessment is a guiding path that balances innovation with safety and regulatory standards.

What is regulatory feasibility assessment? 

Regulatory feasibility assessment determines the possibility of a clinical trial to be conducted according to the clinical trial rules and compliances in that specific geographic region while also considering the costs, timeliness, and other necessary factors. This ensures that:

• Clinical trials meet the necessary rules and regulations locally, regionally, and internationally without compromising clinical trial objectives.
• If trial plans meet legal requirements.
• Helps with quicker approvals and smoother implementation. 
• Fastens the process: clinical trial strategies that comply with legal criteria are more likely to be approved and implemented.
• Beyond legal and regulatory compliance, regulatory feasibility assessment also considers patient safety and the ethical guidelines of clinical trials.
• Ensures that clinical trials are lawful, ethical, and practical. 

What’s the impact of regulatory feasibility assessment in your clinical trial? 

As previously noted above, regulatory feasibility assessment is required to guarantee that clinical trials comply with the applicable laws and regulations. A clear grasp of regulatory requirements makes for better and longer-term outcomes. The following points explain it further. 

1. Identify gaps in current regulations

Regulatory feasibility assessment helps to ensure no concerns with current rules and regulations, such as outdated rules or any other issues that may delay the approval process. By assessing these concerns, clinical trial investigators can ensure that clinical trials adhere to the proper regulations. 

2. Balance strict regulations 

Feasibility assessment strikes the compromise between strict regulations and flexibility and allows novel innovations to access the market. This balance ensures that the clinical trials adhere to the specific norms and regulations without creating a disagreeable experience for investigators. 

3. Cover the ethical standards of the clinical trial 

Adherence to ethical standards is essential in a clinical trial. Regulatory feasibility assessment ensures that ethical principles, including transparency, consent, and patient rights, are considered and addressed. 

4. Ensure safety and participant protection

Regulatory feasibility assessment ensures that participants’ safety has been taken into consideration even before starting the clinical trial, reducing potential adverse outcomes in the future. 

5. Streamline the regulatory process

The streamlined regulatory process eliminates regulatory approval delays and ensures that clinical trials adhere to timelines by detecting potential bottlenecks. 

6. Resource allocation 

Without compromising quality, regulatory feasibility assessment focuses on cost-effectively allocating resources to meet regulatory requirements. 

What factors should be considered during the regulatory feasibility assessment? 

As we briefly discussed above, there are several factors to consider during a feasibility assessment to improve the outcome of your clinical trial. The following table provides a concise overview of the feasibility factors to consider during the regulatory feasibility assessment.

Clinical trial factors	Considerations
Target disease	● Is it a new treatment or an existing spectrum?  ● Standard care comparison  ● Laboratory and study design capabilities
The study design	● How to choose the appropriate study design ● The study design could be randomized, blind, controlled, uncontrolled, etc
Regulatory hurdles	● Any government-related issues in the clinical trial  ● Whether the clinical trial is ethically and scientifically acceptable  ● Does this clinical trial protect the participant’s interests?
Patient recruitment	● Inclusion and exclusion criteria  ● Challenges in recruitment  ● Patient Monitoring
Site selection	● Identifying the potential site ● Geography ● Assessing facilities ● Location ● Patient population ● Competition
Staffing	● Whether the staff has the required qualifications and experience  ● Adequate number of staffing
Timeline	● Start-up timelines ● Is there ample time to proceed?

What are the types of feasibility assessments? 

There are three types of feasibility assessments. Each can be described as follows: 

1. Program level

• This is the highest level of feasibility assessment.
• Typically conducted during the early stages of the clinical trial.
• The goal is to determine the prevalence of a particular disease in a specific region and, to evaluate which region can be used for more specific study-level possibilities.
• The important stages include epidemiological analysis, healthcare infrastructure, and regulatory overview.

2. Study level

• Determine whether a clinical trial can be conducted in a particular region or a country. 
• Evaluate the suitability of a region or a country for a specific clinical trial.
• Identify possible risks and challenges.
• The important stages are patient analysis, investigator evaluation, and site review.

3. Site or investigator-level

• The most granular level of the feasibility assessment.
• Evaluate the suitability of a clinical trial site and investigator for the clinical trial.
• Identify challenges and probable solutions. 
• Investigator and site evaluation are the key steps.

What are the challenges in regulatory feasibility assessment? 

If you don’t approach the regulatory feasibility assessments appropriately, every process step could be challenging. Challenges could be regulatory-related, region-specific, site-specific, legal or ethical. Addressing these challenges effectively is mandatory for the smooth operation of the clinical trial. Below are some of the challenges you might encounter during the process. 

1. Resource limitation 

• Limited financial or human resources might make the process more difficult and disrupt the flow.
• Financial constraints hinder the use of new technologies and experienced workers. 
• Human resource limitations, such as a lack of staff, also impact the smooth operation of the process. 

2. Multi-country trials 

• Multi-country trials can be complex due to varying legislation and customs. 
• Proper planning and understanding of each country’s cultural and legal aspects is necessary before beginning the procedure.

3. Advancing technology 

• Technological advancement can be either an opportunity or a challenge.
• Technology is constantly evolving, and being updated and adapted to it is mandatory.
• Introducing new technologies into the current schedule may be difficult and require proper training and regular upgrades.
• It can be expensive to enroll new technologies into current schedules. 
• With the development of technologies, attention to cyber security is crucial.

4. Ethical considerations 

• Ethical considerations vary by country and can be challenging to follow. 
• It is important to prioritize informed consent, patient data security, and obtaining permission from an ethics committee and institutional review board. 
• Cultural respect should also be considered. 

5. Communication gaps

• Communication gaps between participants, stakeholders, the ethics committee, and investigators can lead to misconceptions and delays in decision-making.

The obstacles listed above are just a handful of the possible ones. Addressing these problems effectively and sensibly will allow the clinical study to function successfully. 

Conclusion

The regulatory feasibility assessment is one of the most crucial steps to take before beginning the clinical study. It ensures that clinical trials are conducted according to the necessary norms and regulations for the specific location, as well as that the A to Z of the clinical trial process is thoroughly checked and established, thereby smoothing and speeding up the procedure. However, it can be difficult at times, but addressing those challenges skillfully and ensuring that everything runs smoothly is worthwhile in the long run. 

---

Do You Have Any Questions or Require Further Information About Regulatory Feasibility Assessment In Clinical Trials?

If you need more details about regulatory feasibility assessments, do not hesitate to contact one of our expert team members; they are always ready to assist and guide you throughout the process.

---